Shoreline Pharmaceutical Private Limited
About Shoreline Pharmaceutical Private Limited
Data last updated:
Shoreline Pharmaceutical Private Limited is a private limited company based in Varanasi, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24297UP2019PTC112540. Its GSTIN is 09ABBCS4517P1ZU (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ashish Kumar Pathak and Vibhoti Pratap Deo.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B31/41A – 1 Bhogabir Lanka, Varanasi, Uttar Pradesh, India – 221005.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.16 Lakh, a decline of 14% compared to the previous year. For the same year it recorded a net profit of ₹2,762 (net margin 0.7%) and EBITDA of ₹5,485 (EBITDA margin 1.3%). Revenue has grown at a compounded annual rate (CAGR) of 144% over three years and 21% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Shoreline Pharmaceutical Private Limited's registered office is in Varanasi, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressB31/41A – 1 Bhogabir Lanka, Varanasi, Uttar Pradesh, India – 221005
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Shoreline Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Shoreline Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Shoreline Pharmaceutical Private Limited, buy the company report.
Financials of Shoreline Pharmaceutical Private Limited
FY 2025 filings availableShoreline Pharmaceutical Private Limited reported revenue of ₹4.16 Lakh (down 14% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 14% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 21%. EBITDA fell 62% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5,485 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2,762 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.3% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Shoreline Pharmaceutical Private Limited, buy the company report.
Board of directors of Shoreline Pharmaceutical Private Limited
Shoreline Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashish Kumar Pathak | Director | 17 Jan 2019 | 7 Years 9 Months | Current |
| Vibhoti Pratap Deo | Director | 17 Jan 2019 | 7 Years 9 Months | Current |
Legal cases
No court or tribunal cases involving Shoreline Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Shoreline Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Shoreline Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09ABBCS4517P1ZU | Uttar Pradesh | Active | 17 Jan 2019 |
To see the full GST registrations and return filing status of Shoreline Pharmaceutical Private Limited, buy the company report.
Recent activity
Shoreline Pharmaceutical Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Ashish Kumar Pathak was appointed as Director on 17 Jan 2019.
Frequently asked questions
Shoreline Pharmaceutical is an active private limited company based in Varanasi, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 January 2019 (7+ years old) and is registered under CIN U24297UP2019PTC112540.
Shoreline Pharmaceutical has 2 current directors:
- Ashish Kumar Pathak - Director
- Vibhoti Pratap Deo - Director
The latest financial statements of Shoreline Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Shoreline Pharmaceutical is 09ABBCS4517P1ZU, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Shoreline Pharmaceutical is U24297UP2019PTC112540. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shoreline Pharmaceutical was incorporated on 17 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Ashish Kumar Pathak was appointed as Director on 17 Jan 2019. Vibhoti Pratap Deo was appointed as Director on 17 Jan 2019.
The registered office of Shoreline Pharmaceutical is at B3141A – 1 Bhogabir Lanka, Varanasi, Uttar Pradesh, India – 221005.
Shoreline Pharmaceutical operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Shoreline Pharmaceutical is compliant as of 26 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
